Pharmaceutical

Cyltezo Pen: first interchangeable biosimilar to Humira rolls out across US

The Humira biosimilar from Boehringer Ingelheim launches amidst a loss of exclusivity for AbbieVie’s blockbuster drug.

Jul 3, 2023 - 20:00
Cyltezo Pen: first interchangeable biosimilar to Humira rolls out across US
The Humira biosimilar from Boehringer Ingelheim launches amidst a loss of exclusivity for AbbieVie’s blockbuster drug.
Read the original article

Tags:

Previous Article

Generative AI – beyond the hype

Next Article

Eli Lilly’s retatrutide sets new record for weight loss in obesity space

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Risk adjusted net present value: What is the current va...

Jul 2, 2024

The White House has a pharmacy — and it was a mess, a new investigation found

The White House has a pharmacy — and it was a mess, a n...

Jan 24, 2024

After decades of neglecting women athletes, sport and exercise medicine is finally catching up

After decades of neglecting women athletes, sport and e...

May 19, 2023